Literature DB >> 7717403

The 18q- syndrome: analysis of chromosomes by bivariate flow karyotyping and the PCR reveals a successive set of deletion breakpoints within 18q21.2-q22.2.

G A Silverman1, S S Schneider, H F Massa, A Flint, M Lalande, J C Leonard, J Overhauser, G van den Engh, B J Trask.   

Abstract

The 18q- syndrome is one of several terminal deletion disorders that occur in humans. Previous G-banding studies suggest that the loss of a critical band, 18q21.3, results in mental retardation, craniofacial anomalies, and metabolic defects. However, it is difficult to reconcile the consistent loss of a single region with the large variability in clinical phenotype. The purpose of this study was to reassess the extent of chromosomal loss in a cohort of 17 18q- syndrome patients by using fluorescent-activated chromosome sorting, PCR, and FISH. Bivariate flow karyotypes revealed heterogeneity among the deletions; they ranged in size from 9 to 26 Mb. To confirm this heterogeneity at a molecular level, deleted and normal chromosomes 18 of six patients were collected by flow sorting, preamplified by random priming, and assayed for marker content by the PCR. This analysis defined five unique breakpoints among the six patients. We conclude that the terminal deletions in the 18q- syndrome occur over a broad region spanning the interval from 18q21.2 to 18q22.2. Our results suggest that the variability in clinical phenotype may be more representative of a contiguous-gene syndrome with a baseline deficit of 18q22.2-qter than of the loss of a single critical region within 18q21.3.

Entities:  

Mesh:

Year:  1995        PMID: 7717403      PMCID: PMC1801205     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

1.  Report and abstracts of the second international workshop on human chromosome 18 mapping. Doorwerth, the Netherlands, July 19-20, 1993.

Authors:  A G van Kessel; R E Straub; G A Silverman; S Gerken; J Overhauser
Journal:  Cytogenet Cell Genet       Date:  1994

2.  PCR probes for chromosome in situ hybridization of large-insert bacterial recombinants.

Authors:  P M Kroisel; P A Ioannou; P J de Jong
Journal:  Cytogenet Cell Genet       Date:  1994

3.  Chromosomal reassignment: YACs containing both YES1 and thymidylate synthase map to the short arm of chromosome 18.

Authors:  G A Silverman; W L Kuo; P Taillon-Miller; J W Gray
Journal:  Genomics       Date:  1993-02       Impact factor: 5.736

Review 4.  Molecular analysis of the 18q- syndrome--and correlation with phenotype.

Authors:  A D Kline; M E White; R Wapner; K Rojas; L G Biesecker; J Kamholz; E H Zackai; M Muenke; C I Scott; J Overhauser
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

5.  Preimplantation single cell analyses of dystrophin gene deletions using whole genome amplification.

Authors:  K Kristjansson; S S Chong; I B Van den Veyver; S Subramanian; M C Snabes; M R Hughes
Journal:  Nat Genet       Date:  1994-01       Impact factor: 38.330

6.  Interstitial deletions are not the main mechanism leading to 18q deletions.

Authors:  G Strathdee; W Harrison; H C Riethman; S A Goodart; J Overhauser
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

7.  Digitized and differentially shaded human chromosome ideograms for genomic applications.

Authors:  U Francke
Journal:  Cytogenet Cell Genet       Date:  1994

8.  Genetic transfer and expression of reconstructed yeast artificial chromosomes containing normal and translocated BCL2 proto-oncogenes.

Authors:  G A Silverman; E Yang; J H Proffitt; M Zutter; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

9.  Evidence for a recessive PMP22 point mutation in Charcot-Marie-Tooth disease type 1A.

Authors:  B B Roa; C A Garcia; L Pentao; J M Killian; B J Trask; U Suter; G J Snipes; R Ortiz-Lopez; E M Shooter; P I Patel; J R Lupski
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

10.  18q+, the progeny of a balanced translocation t(1;18)mat: case report with necropsy findings.

Authors:  A Hindi; D Beneck; M A Greco; S R Wolman
Journal:  J Med Genet       Date:  1986-06       Impact factor: 6.318

View more
  7 in total

1.  A new deletion of 18q23 with few typical features of the 18q- syndrome.

Authors:  M Kohonen-Corish; G Strathdee; J Overhauser; T McDonald; V Jammu
Journal:  J Med Genet       Date:  1996-03       Impact factor: 6.318

2.  Molecular characterization of patients with 18q23 deletions.

Authors:  G Strathdee; R Sutherland; J J Jonsson; R Sataloff; M Kohonen-Corish; D Grady; J Overhauser
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

3.  Trisomy 4p and partial monosomy 18q due to paternal translocation t(4;18) (p11; q21.3).

Authors:  G Thanemozhi; S T Santhiya; N Chandra; G Palka; S Jayam; P M Gopinath
Journal:  Indian J Pediatr       Date:  2000-08       Impact factor: 1.967

4.  PA26 is a candidate gene for heterotaxia in humans: identification of a novel PA26-related gene family in human and mouse.

Authors:  H Peeters; P Debeer; A Bairoch; V Wilquet; C Huysmans; E Parthoens; J P Fryns; M Gewillig; Y Nakamura; N Niikawa; W Van de Ven; K Devriendt
Journal:  Hum Genet       Date:  2003-02-27       Impact factor: 4.132

Review 5.  Chromosomes in the flow to simplify genome analysis.

Authors:  Jaroslav Doležel; Jan Vrána; Jan Safář; Jan Bartoš; Marie Kubaláková; Hana Simková
Journal:  Funct Integr Genomics       Date:  2012-08-16       Impact factor: 3.410

6.  Complex chromosome rearrangement in a child with microcephaly, dysmorphic facial features and mosaicism for a terminal deletion del(18)(q21.32-qter) investigated by FISH and array-CGH: Case report.

Authors:  Emmanouil Manolakos; Nadezda Kosyakova; Loreta Thomaidis; Rozita Neroutsou; Anja Weise; Markos Mihalatos; Sandro Orru; Haris Kokotas; George Kitsos; Thomas Liehr; Michael B Petersen
Journal:  Mol Cytogenet       Date:  2008-11-11       Impact factor: 2.009

Review 7.  Hypothesis of the neuroendocrine cortisol pathway gene role in the comorbidity of depression, type 2 diabetes, and metabolic syndrome.

Authors:  Claudia Gragnoli
Journal:  Appl Clin Genet       Date:  2014-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.